Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05266066

Ventilator-associated Tracheobronchitis Initiative to Conduct Antibiotic Evaluation

Multicenter Randomized Clinical Trial of Antimicrobial Treatment in Ventilator-associated Tracheobronchitis

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
590 (estimated)
Sponsor
Hospital Sirio-Libanes · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The Ventilator Associated tracheobronchitis Initiative to Conduct Antibiotic evaluation (VATICAN) trial is a national, multicenter, non-inferiority trial in ICU patients comparing antibiotic treatment for 7 days versus clinical observation without antibiotic treatment for patients with ventilator-associated tracheobronchitis.

Detailed description

There is no consensus on the need for antibiotic treatment for ventilator-associated tracheobronchitis (VAT). There's a lack of high-quality clinical data on this subject, and although some observational studies recommend antibiotic treatment for VAT, some guidelines do not. The VATICAN is a prospective, randomized, single-blinded (analysis), non-inferiority trial evaluating antibiotic treatment for patients with ventilator-associated tracheobronchitis. Patients with clinically diagnosed tracheobronchitis will be randomized to receive antibiotics for 7 days versus clinical observation without antibiotic treatment for VAT. The primary hypothesis is that clinical observation without antibiotic treatment is noninferior to 7-day antibiotic course.

Conditions

Interventions

TypeNameDescription
OTHERClinical observation without antibiotic therapy for VATPatients will receive standard care plus antibiotic if new organ dysfunction or new infections other than VAT.
OTHER7 day antibiotic course for VATPatients will receive standard care plus 7 day course of antibiotic.

Timeline

Start date
2022-07-11
Primary completion
2026-11-01
Completion
2026-12-01
First posted
2022-03-04
Last updated
2025-06-19

Locations

16 sites across 1 country: Brazil

Source: ClinicalTrials.gov record NCT05266066. Inclusion in this directory is not an endorsement.